Merck & Co.'s Stock Falls 8.75% Amid Weak Gardasil Sales in China
Merck & Co.'s stock faced an 8.75% drop in 2024, linked to reduced Gardasil vaccine sales in China. Explore the impact on Merck's market performance.
Merck & Co.'s stock price decreased by 8.75% in 2024, primarily due to a decline in Gardasil vaccine sales in China.